Download - Bayer HealthCare

More documents

Recommendations

Info

High-quality active ingredients are fi lled at the Supply Center in Bergkamen. 20 Product Supply
Bayer HealthCare manufactures products at almost 60 sites around the world which are managed by Product Supply. The production of active ingredients for prescription medicines is conducted primarily at the production sites in Wuppertal and Bergkamen (Germany) and Berkeley and Emeryville (united States). They are processed and packaged as finished pharmaceuticals in plants around the world. A broad spectrum of different pharmaceutical presentations is covered: solid formulations such as tablets, sugar-coated tablets and powders, semi-solid ointments and creams, and liquid drug products for application, for example, as injections or infusions. Hormonal contraceptives are produced as sugar- or film-coated tablets but also, for example, as intrauterine systems. These formulation and packaging activities are based in Berlin, Leverkusen and Weimar (Germany), Garbagnate (Italy), Turku (Finland), São Paulo (Brazil), Beijing (China), as well as various other sites in Europe, Asia and Latin America. Kogenate, a drug product for the treatment of hemophilia, is manufactured in Berkeley (United States) using a biotechnology process, while Betaferon/Betaseron for the treatment of multiple sclerosis is produced in Emeryville (United States). The main production sites for non-prescription (over-the-counter) drug products are located in Bitterfeld-Wolfen and Grenzach-Wyhlen (Germany), Cimanggis (Indonesia), Lerma (Mexico), Myerstown (United States) and Madrid (Spain). The globally marketed animal health products are mainly manufactured at the sites in Kiel (Germany) and Shawnee (United States). In addition to drug products for humans and animals, medical devices for diagnosis and therapy are produced in the United States. Bayer HealthCare supplies a total of more than 20,000 articles. The reason for this large number is the different presentations of individual products and packaging – for example, different formulations, dosages, pack sizes and language versions. Bayer HealthCare Product Supply steers the subgroup’s entire supply chain, from raw material sourcing through manufacturing to distribution, utilizing a global production network consisting of its own sites and those of contract manufacturers. In this way the company aims for continuous improvement of costs, flexibility and delivery reliability, maintaining high standards of quality, health, safety and environmental protection on a global basis. The manufacture of pharmaceutical products is subject to extraordinarily stringent quality standards. These standards are known collectively as “Good Manufacturing Practice” (GMP). Compliance with these requirements is regularly audited by internal experts, regulatory authorities and external consultants. ProDuCT SuPPly 21
Page 1 and 2: Bayer HealthCare A Company Overview
Page 3 and 4: innovations in health care Bayer He
Page 5 and 6: or farm animals for food production
Page 7 and 8: The goals of the Animal Health Divi
Page 9 and 10: A growing number of individuals wor
Page 11 and 12: Bayer HealthCare’s Medical Care D
Page 13 and 14: Bayer HealthCare’s success story
Page 15 and 16: Continued from page 13 of the uteru
Page 17 and 18: €1,962 million of the Bayer Group
Page 19: expertise. The current R&D focus in
Page 23 and 24: As an innovation- and growth-orient
Page 25 and 26: in the 21st century, the world will
Page 27 and 28: Bayer HealthCare names - Figures -
Page 29 and 30: Germany United States China Japan M

Download - Bayer HealthCare

Create successful ePaper yourself

Delete template?

Save as template?